EMS-Chemie reports CHF 310 million income as EMS-Chemie stock sits 1.15 percent below its high

Published on 10/13/2026 at 02:53 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

First-half net sales were CHF 1,012 million, down 0.78 percent year over year. UBS rates EMS-Chemie stock Buy at CHF 860.

Key points in brief

EMS-Chemie reported CHF 310 million in net operating income for the first half of 2026.
First-half net sales were CHF 1,012 million, down 0.78 percent year over year.
The SIX-listed stock was last at CHF 859.00 on October 12, 2026, 1.15 percent below its 52-week high.
Seven analysts have a Neutral consensus, with an average 12-month target of CHF 732.14.

Schwarzweiß-Reportage aus einem Chemiewerk, EMS-Chemie Holding AG — Schwarzweiß-Reportagefoto von Werksarbeitern illustriert die Industrie von EMS-Chemie Holding AG, ISIN CH0016440353, dokumentarisch fotografiert, Illustration mit AI erstellt.

EMS-Chemie reported CHF 310 million in net operating income for the first half of 2026, up 4.73 percent from CHF 296 million in the year-earlier period, according to EMS-Chemie on August 28, 2026. EMS-Chemie stock was 1.15 percent below its CHF 869.00 52-week high recorded on October 9, 2026.

Half-year margin stays above 30 percent

Net sales reached CHF 1,012 million in the first half of 2026, down 0.78 percent from CHF 1,020 million in the first half of 2025. Net operating income therefore represented a 30.63 percent margin, compared with 29.02 percent a year earlier.

The figures show the effect of EMS-Chemie's specialty-focused model: operating income increased while sales declined. The combination gives investors a more useful signal than revenue alone because profitability improved by 1.61 percentage points.

What do the analyst targets imply?

Investing.com lists a Neutral consensus based on seven analysts, with two Buy ratings, four Holds and one Sell. The average 12-month target is CHF 732.14, while the highest target is CHF 860.00 and the lowest is CHF 630.00.

The most recent named rating in the overview is UBS at Buy with a CHF 860.00 target, maintained on July 23, 2026. That target is 0.12 percent above the CHF 859.00 last price shown for the SIX listing, while the average target is 14.77 percent below that price.

Three dated signals for EMS-Chemie

On July 10, 2026, EMS-Chemie reported first-half net sales of CHF 1,012 million and net operating income of CHF 310 million through its investor-relations communications. On August 28, 2026, the company published the definitive half-year results and confirmed that the provisional figures had changed only marginally. On October 12, 2026, EMS-Chemie stock traded at CHF 862.50 during the early SIX session, according to finanzen.ch.

Fakuma runs through October 16

The next dated company event is Fakuma 2026, which runs through October 16, 2026. EMS-GRIVORY is presenting product innovations at booth 2113 in hall B2, according to EMS-GRIVORY.

Stock remains below the yearly high

The latest structured quote for the SIX listing put EMS-Chemie at CHF 859.00 on October 12, 2026 at 5:30 p.m. CEST, with a 52-week range of CHF 530.00 to CHF 869.00. The market capitalization was CHF 20.1 billion at that timestamp.

The further course of trading is shown by the continuously updated real-time quote of EMS-Chemie stock.